G. M. de la Calle

发表

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

A. Villaflor, M. Pfeffer, C. Held, 2021, European heart journal.

Does admission acetylsalicylic acid uptake in hospitalized COVID-19 patients have a protective role? Data from the Spanish SEMI-COVID-19 Registry

J. Fayós, Manuel Cebrian, M. Bernabeu-Wittel, 2021, Internal and Emergency Medicine.

Respiratory support in patients with severe COVID-19 in the International Severe Acute Respiratory and Emerging Infection (ISARIC) COVID-19 study: a prospective, multinational, observational study

C. A. Shaw, Eglantine Ferrand Devouge, Su Hwan Lee, 2022, Critical Care.

Tocilizumab for the treatment of adult patients with severe COVID‐19 pneumonia: A single‐center cohort study

H. Bueno, J. Aguado, C. Lumbreras, 2020, Journal of medical virology.

Pseudomonas aeruginosa Bloodstream Infections in Patients with Cancer: Differences between Patients with Hematological Malignancies and Solid Tumors

P. Martín-Dávila, R. Araos, M. Akova, 2022, Pathogens.

Validation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry

Miguel Ángel Martínez, Yale Tung Chen, Manuel Cebrian, 2023, Internal and Emergency Medicine.

Prior Treatment with Statins is Associated with Improved Outcomes of Patients with COVID-19: Data from the SEMI-COVID-19 Registry

Miguel Ángel Martínez, J. Fayós, Manuel Cebrian, 2021, Drugs.

Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19

H. Bueno, E. Paz-Artal, J. Aguado, 2022, International Journal of Infectious Diseases.

Combination therapy with tocilizumab and corticosteroids for aged patients with severe COVID-19 pneumonia: A single-center retrospective study

H. Bueno, E. Paz-Artal, J. Aguado, 2020, International Journal of Infectious Diseases.